Alira Health and Sancare announce real-world data partnership to drive healthcare innovation

Alira Health and Sancare partner to create a French real-world data (RWD) platform integrating electronic medical records and claims with artificial intelligence.

Alira Health, a global advisory and clinical research firm, and Sancare, a technology and hospital data specialist, have announced they are joining forces to establish an RWD platform in France to advance real-world insights in healthcare development. The platform, Realli™, will comprise of deep hospital electronic medical record (EMR) data linked with claims from an expanding federated network of French hospitals, augmented with artificial intelligence (AI).

Uniting Alira Health’s life sciences experience with Sancare’s expertise in application of AI machine learning to hospital data systems, the pair will form a platform of linked EMR and claims data from a solid and growing network of hospitals in France. Realli will provide near real-time access to the full content EMRs from its partner hospitals. This platform will facilitate the analysis of RWD and the generation of real-world evidence (RWE), addressing gaps in evidence and accelerating innovation.

“Through the partnership between Alira Health and Sancare, we combine our strengths to create a comprehensive end-to-end service offering that enables data access, analytics, and evidence generation strategy, providing impactful real-world solutions with purpose for patients,” said Jean-François Ricci, Chief Access Officer at Alira Health. “Our collaboration creates a central source for study design, data analysis, and communication of actionable insights that address needs for clinical research and market access in France and beyond.”

“Our partnership brings new capabilities for healthcare and life sciences organizations, especially for RWE studies and for data owners,” said Thomas Duval, CEO of Sancare. “By uniting Alira Health’s strengths as a Global Advisory and Contract Research Organization (CRO) with Sancare’s technology, data, and network, we enable important new evidence resources for companies developing solutions for patients.”